Andrew F. Shorr

Epidemiology and Outcomes of Health-care–Associated Pneumonia

Marin H. Kollef, Andrew F. Shorr, Ying P. Tabak et al. · CHEST Journal · 2005 · 951 citations

Medicine, Infectious Diseases, Internal Medicine +12

Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

Christopher J. Lettieri, Steven D. Nathan, Scott D. Barnett et al. · CHEST Journal · 2006 · 871 citations

Medicine, Cardiology, Internal Medicine +13

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

Richard G. Wunderink, Michael S. Niederman, Marin H. Kollef et al. · Clinical Infectious Diseases · 2012 · 573 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu et al. · The Lancet Infectious Diseases · 2020 · 464 citations

Pharmacy, Clinical Sciences, Infectious Diseases +17

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant

Andrew F. Shorr, J.L. Wainright, Cindy Cors et al. · European Respiratory Journal · 2007 · 371 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15